11～15_泌尿器系
| 11_腎癌 | 12_尿路上皮癌 |
| 13_前立腺癌 | 14_精巣腫瘍 |
| 15_陰茎癌 | |
11_腎癌
01-01_Avelumab+Axitinib PDF 03-01_肝胆膵原発神経内分泌腫瘍CDDP+ETP PDF 09-01_IL-2+IFN-alpha+UFT PDF 14-01_nivolumab(R) PDF 14-03_nivolumab+ipilimumab PDF 14-05_nivolumab+cabozantinib PDF 15-01_オニバイド+5-FU／LV PDF 16-01_Pembrolizumab+Axitinib PDF 16-02_Pembrolizumab (腎細胞癌 adjuvant) PDF 16-04_Pembrolizumab+Lenvatinib PDF 19-03_STZ+5-FU PDF 20-20_TMB-High Pembrolizumab(腎癌) PDF
12_尿路上皮癌
01-01_Avelumab PDF 03-01_CBDCA+GEM PDF 03-02_CBDCA+VP-16(uro) PDF 03-03_CDDP80+VP-16(uro) PDF 03-04_集合管癌CBDCA+GEM PDF 03-05_膀胱小細胞CDDP+CPT-11 PDF 05-01_Enfortumab vedtin PDF 07-01_GC PDF 07-02_GP PDF 13-01_MVAC PDF 14-01_nivolumab(尿路上皮癌、adjuvant） PDF 16-01_Pembrolizumab(uro) PDF 20-01_TMB-High Pembrolizumab(尿路上皮癌) PDF
13_前立腺癌
01-01_AMR(prostate) PDF 03-01_前立腺癌カバジタキセル療法 PDF 03-02_CDDP+CPT-11(prostate) PDF 04-01_DOC70 PDF 20-01_TMB-High Pembrolizumab(前立腺癌) PDF
14_精巣腫瘍
15_陰茎癌
13-01_MPB PDF 13-02_MSI-High Pembrolizumab(陰茎癌) PDF 20-01_TMB-High Pembrolizumab(陰茎癌) PDF
